
Reeta Asmai/UC Davis
The goal at the Immuno-modulatory Biomaterials Laboratory (IMBL) in the Department of Biomedical Engineering at the University of California, Davis is to design the next generation of immunotherapeutics for applications in immune-related diseases.
Comments
There are no comments on this report. Sorry, comments are closed.